An antagonistic IL-4 mutant prevents type I allergy in the mouse: Inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 4004-4009

  Grunewald, Susanne M ^a   Werthmann, Antje ^a   Schnarr, Bernd ^a   Klein, C Eberhard ^a   Bröcker, Eva B ^a,c   Mohrs, Markus ^b   Brombacher, Frank ^b   Sebald, Walter ^a   Duschl, Albert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ALLERGY; ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032522641     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Paul, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859.
2. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
3. Romagnani, S. 1997. The TH1/TH2 Paradigm in Disease. R. G. Landes Company, Austin, TX.
4. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
5. Tony, H.-P., B.-J. Shen, P. Reusch, and W. Sebald. 1994. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur. J. Biochem. 225:659.
6. Smerz-Bertling, C., and A. Duschl. 1995. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 270:966.
7. Kruse, N., H. P. Tony, and W. Sebald. 1992. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 11:3237.
8. Kruse, N., B. J. Shen, S. Arnold, H. P. Tony, T. Müller, and W. Sebald. 1993. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12:5121.
9. Zurawski, S. M., F. Vega, B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
10. Aversa, G., J. Punnonen, B. G. Cocks, R. de Waal Malefyt, F. Vega, S. M. Zurawski, G. Zurawski, and J. E. de Vries. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178:2213.
11. Zurawski, S. M., P. Chomarat, O. Djossou, C. Bidaud, A. N. J. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869.
12. König, B., A. Fischer, and W. König. 1995. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D). Immunology 85:604.
13. Carballido, J. M., D. Schols, R. Namikawa, S. Zurawski, G. Zurawski, M.-G. Roncarolo, and J. E. de Vries. 1995. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. J. Immunol. 155:4162.
14. Carballido, J. M., G. Aversa, D. Schols, J. Punnonen, and J. E. de Vries. 1995. Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist. Int. Arch. Allergy Immunol. 107:304.
15. Schnyder, B., S. Lugli, N. Feng, H. Etter, R. A. Lutz, B. Ryffel, K. Sugamura, H. Wunderli-Allenspach, and R. Moser. 1996. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain. Blood 87:4286.
16. + T cells, analyzed at the single-cell level. J. Exp. Med. 184:473.
17. Vannier, E., R. de Waal Malefyt, A. Salazar-Montes, J. E. de Vries, and C. A. Dinarello. 1996. Interleukin-13 (IL-13) induces IL-I receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. Blood 8:3307.
18. Schnarr, B., J. Ezernieks, W. Sebald, and A. Duschl. 1997. Interleukin-4 receptor complexes containing or lacking the γc chain are inhibited by an overlapping set of antagonistic interleukin-4 mutant proteins. Int. Immunol. 9:861.
19. Grunewald, S. M., S. Kunzmann, B. Schnarr, J. Ezernieks, W. Sebald, and A. Duschl. 1997. A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. J. Biol. Chem. 272:1480.
20. Andersson, A., S. M. Grunewald, A. Duschl, A. Fischer, and J. P. DiSanto. 1997. Mouse macrophage development in the absence of the common γ chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur. J. Immunol. 27:1762.
21. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Köhler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
22. Renz, H., H. R. Smith, J. E. Henson, B. S. Ray, C. G. Irvin, and E. W. Gelfand. 1992. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway rcsponsiveness in the mouse. J. Allergy Clin. Immunol. 89:1127.
23. Morawetz, R. A., L. Gabriele, L. V. Rizzo, N. Noben-Trauth, R. Kühn, K. Rajewsky, W. Müller, T. M. Doherty, F. Finkelman, R. L. Coffman, and H. C. Morse. 1996. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. J. Exp. Med. 184:1651.
24. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr., J. Holmes, J. Ohara, A. S. Tung, J. Sample, and W. E. Paul. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335.
25. Sato, T. A., M. B. Widmer, F. D. Finkelman, H. Madani, C. A. Jacobs, K. H. Grabstein, and C. R. Maliszewski. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717.
26. Maliszewski, C. R., T. A. Sato, B. Davison, C. A. Jacobs, F. D. Finkelman, and W. C. Fanslow. 1994. In vivo biological effects of recombinant soluble interleukin-4 receptor. Proc. Soc. Exp. Biol. Med. 206:233.
27. Renz, H., K. Enssle, L. Lauffer, R. Kurrle, and E. W. Gelfand. 1995. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int. Arch. Allergy Immunol. 106:46.
28. Renz, H., K. Bradley, K. Enssle, J. E. Loader, and E. W. Gelfand. 1996. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int. Arch. Allergy Immunol. 109:167.
29. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151:1235.
30. Coffman, R. L., D. A. Lebman, and P. Rothman. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229.
31. Oettgen, H. C., T. R. Martin, A. Wynshaw-Boris, C. Deng, J. M. Drazen, and P. Leder. 1994. Active anaphylaxis in IgE-deficient mice. Nature 170:367.
32. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92:11931.
33. Fujieda, S., K. Zhang, and A. Saxon. 1995. IL-4 plus CD40 monoclonal antibody induces human B cells γ subclass-specific isotope switch: switching to γ1, γ3, and γ4, but not γ2. J. Immunol. 155:2318.
34. Shparago, N., P. Zelazowski, L. Jin, T. M. McIntyre, E. Stüber, L. M. T. Pecanha, M. R. Kehry, J. J. Mond, E. E. Max, and C. M. Snapper. 1996. IL-10 selectively regulates murine Ig isotope switching. Int. Immunol 8:781.
35. Holt, P. G., A. H. Rose, J. E. Batty, and K. J. Turner. 1981. Induction of adjuvant-independent IgE responses in inbred mice: primary, secondary, and persistent IgE responses to Ovalbumin and Ovomucoid. Int. Arch. Allergy Appl. Immunol. 65: 42.
36. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.